|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Operating expenses | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Other income (expense): | |||||
| Loss from equity method investment | |||||
| (Loss) gain on changes in other fair value adjustments | |||||
| Gain on change in fair value of warrant liability | |||||
| Interest expense | |||||
| Interest income | |||||
| Loss on disposal of assets | |||||
| Impairment charges | |||||
| Total other income | |||||
| (Loss) income from continuing operations | |||||
| Gain from discontinued operations | |||||
| Net (loss) income | |||||
| Net (loss) income per share | |||||
| Basic (in USD per shares) | |||||
| Diluted (in USD per shares) | |||||
| Weighted-average shares of common stock outstanding | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...